Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
Description: PUBLIC HEALTH RELEVANCE: As a Network Lead Academic Participating Site MSKCC will be a leader in the scientific development, conduct and accrual of NCTN clinical trials with the overall goal of developing new treatments for cancer patients. This will be achieved through definitive, randomized, clinical treatment and advanced imaging trials across a broad range of diseases and diverse patient populations, as well as development efforts preliminary to those trials.
Funder: National Cancer Institute
Funding type: cooperative_agreement
Funder scheme: U10
Start date: 2014-04-15
End date: 2019-02-28
Investigator: CAROL AGHAJANIAN
Institution: SLOAN-KETTERING INST CAN RESEARCH
Funded outputs count: 115
Funder award ID: U10CA180791
OpenAlex ID: G1972092201